Global Nosocomial Infection Treatment Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Nosocomial Infection Treatment market size will reach US$ million by 2031.
Nosocomial infection, also known as hospital acquired or associated infection (HAI) is defined as an infection developed in patients during the hospital stay that was earlier not present or incubated during admission in the hospital.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LPI (LP Information)' newest research report, the “Nosocomial Infection Treatment Industry Forecast” looks at past sales and reviews total world Nosocomial Infection Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Nosocomial Infection Treatment sales for 2025 through 2031. With Nosocomial Infection Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nosocomial Infection Treatment industry.
This Insight Report provides a comprehensive analysis of the global Nosocomial Infection Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nosocomial Infection Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nosocomial Infection Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nosocomial Infection Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nosocomial Infection Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Nosocomial Infection Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
Antibacterial Treatment
Antiviral Treatment
Antifungal Treatment
Segmentation by Application:
Ventilator Associated Pneumonia
Urinary Tract Infection
Blood Stream Infection
Surgical Site Infection
Gastrointestinal Infection
MRSA
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Bayer
Becton, Dickinson and Company
Belimed
BioMerieux
Cantel
Cepheid
Getinge Group
Kimberly-Clark Corp.
Merck & Co
Nordion
Pfizer
Roche
Sakura Seiki
BioMérieux
Steris
Johnson & Johnson
Sterigenics International, Inc.
Halyard Health, Inc.
Advanced Sterilization Products
Matachana Group
Please note: The report will take approximately 2 business days to prepare and deliver.
Nosocomial infection, also known as hospital acquired or associated infection (HAI) is defined as an infection developed in patients during the hospital stay that was earlier not present or incubated during admission in the hospital.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LPI (LP Information)' newest research report, the “Nosocomial Infection Treatment Industry Forecast” looks at past sales and reviews total world Nosocomial Infection Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Nosocomial Infection Treatment sales for 2025 through 2031. With Nosocomial Infection Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nosocomial Infection Treatment industry.
This Insight Report provides a comprehensive analysis of the global Nosocomial Infection Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nosocomial Infection Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nosocomial Infection Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nosocomial Infection Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nosocomial Infection Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Nosocomial Infection Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
Antibacterial Treatment
Antiviral Treatment
Antifungal Treatment
Segmentation by Application:
Ventilator Associated Pneumonia
Urinary Tract Infection
Blood Stream Infection
Surgical Site Infection
Gastrointestinal Infection
MRSA
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Bayer
Becton, Dickinson and Company
Belimed
BioMerieux
Cantel
Cepheid
Getinge Group
Kimberly-Clark Corp.
Merck & Co
Nordion
Pfizer
Roche
Sakura Seiki
BioMérieux
Steris
Johnson & Johnson
Sterigenics International, Inc.
Halyard Health, Inc.
Advanced Sterilization Products
Matachana Group
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
160 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
